Prentiss Smith & Co’s QIAGEN NV QGENF Stock Holding History

Prentiss Smith & Co’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-69,948	Closed	-$1.39M	–	272
2013 Q2	$1.39M	Buy	+69,948	New	+$1.39M	0.72%	37

Other funds holding QGENF

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Prentiss Smith & Co's QGENF Position: Q3 2013 in Review

Prentiss Smith & Co sold out of QIAGEN NV (QGENF) in Q3 2013, closing a stake of 69,948 shares — an estimated $1.39M sold.

Prentiss Smith & Co first reported a position in QGENF in Q2 2013 and held it in 1 quarter. The position peaked at $1.39M in Q2 2013. 150 funds tracked by Wall St. Rank hold QGENF as of Q3 2013.

Prentiss Smith & Co reported no remaining QIAGEN NV position as of Q3 2013 after selling out during the quarter.
Prentiss Smith & Co sold 69,948 QIAGEN NV shares in Q3 2013, an estimated $1.39M.
Prentiss Smith & Co first reported a position in QIAGEN NV in Q2 2013 and held it in 1 quarter.
Prentiss Smith & Co's QIAGEN NV position peaked at $1.39M in Q2 2013.
150 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2013.

Based on Prentiss Smith & Co's 13F filing for Q3 2013, filed 1 Nov 2013.